ETENDERS

Contract notice

Information

Published

Date of dispatch of this notice: 10/04/2017

Expire date: 12/05/2017

External Reference: 2017-172745

TED Reference: 2017/S 072-136779

Contract notice

Cached Version

Contract notice

Directive 2014/24/EU

Section I: Contracting authority

I.1)

Name and addresses

Irish Blood Transfusion Service
N/A
National Blood Centre, James's Street
Dublin D08 NH5R
Dublin
IE
Contact person: Paul Behan
Telephone: +353 14322846
E-mail: paul.behan@ibts.ie
NUTS code:  IE -  IRELAND
Internet address(es):
Main address: http://www.giveblood.ie
Address of the buyer profile: https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/1186

I.3)

Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at:  
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=111040&B=ETENDERS_SIMPLE
Additional information can be obtained from
the abovementioned address:  
Tenders or requests to participate must be submitted
electronically via:  http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=111040&B=ETENDERS_SIMPLE
Tenders or requests to participate must be submitted
to the abovementioned address
I.4)

Type of the contracting authority

Body governed by public law
I.5)

Main activity

Health

Section II: Object

II.1)

Scope of the procurement

II.1.1)

Title

fully automated Individual Donation Nucleic Acid Amplification Technology (NAT) Testing System
Reference number:  IBTS/010/2017
II.1.2)

Main CPV code

33696200  -  Blood-testing reagents
II.1.3)

Type of contract

Supplies
II.1.4)

Short description

A fully automated system for performing individual donation (ID)- Nucleic Acid Amplification Technology (NAT) testing of IBTS donations in human plasma. The NAT laboratory currently tests approximately 150,000 donations/samples annually. HIV RNA, HCV RNA and HBV DNA NAT testing of IBTS donations and samples in individual donation format. In addition, the system must perform ID-NAT testing for Hepatitis E virus (HEV) and West Nile Virus (WNV) RNA, and future capability for NAT testing of additional viral markers on the proposed system testing platform e.g. Zika virus testing.
The ID-NAT Testing system will include testing reagents, consumables, equipment, operating software, servicing and maintenance.
II.1.5)

Estimated total value

Value excluding VAT: 7400000.00  EUR
II.1.6)

Information about lots

This contract is divided into lots: no
II.2)

Description

II.2.2)

Additional CPV code(s)

33696500  -  Laboratory reagents
38434520  -  Blood analysers
II.2.3)

Place of performance

NUTS code:  IE -  IRELAND
II.2.4)

Description of the procurement

A fully automated system for performing individual donation (ID)- Nucleic Acid Amplification Technology (NAT) testing of IBTS donations in human plasma. The NAT laboratory currently tests approximately 150,000 donations/samples annually. HIV RNA, HCV RNA and HBV DNA NAT testing of IBTS donations and samples in individual donation format. In addition, the system must perform ID-NAT testing for Hepatitis E virus (HEV) and West Nile Virus (WNV) RNA, and future capability for NAT testing of additional viral markers on the proposed system testing platform e.g. Zika virus testing.
The ID-NAT Testing system will include testing reagents, consumables, equipment, operating software, servicing and maintenance.
II.2.5)

Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)

Estimated value

Value excluding VAT: 7400000.00  EUR
II.2.7)

Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 48
This contract is subject to renewal: yes
Description of renewals:  
The IBTS reserves the right to extend the contract for 12 months
II.2.10)

Information about variants

Variants will be accepted: no
II.2.11)

Information about options

Options: no
II.2.13)

Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)

Additional information

The effective contract start date will be from successful validation of equipment and consumables

Section III: Legal, economic, financial and technical information

III.1)

Conditions for participation

III.1.1)

Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

List and brief description of conditions:  As per RFT
III.1.2)

Economic and financial standing

List and brief description of selection criteria:  
As per RFT
III.1.3)

Technical and professional ability

List and brief description of selection criteria:  
As per RFT
Minimum level(s) of standards possibly required:  
As per RFT
III.2)

Conditions related to the contract

Section IV: Procedure

IV.1)

Description

IV.1.1)

Type of procedure

Open procedure
IV.1.8)

Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: yes
IV.2)

Administrative information

IV.2.2)

Time limit for receipt of tenders or requests to participate

Date:  12/05/2017
Local time:  12:00
IV.2.4)

Languages in which tenders or requests to participate may be submitted

English
IV.2.6)

Minimum time frame during which the tenderer must maintain the tender

Tender must be valid until:  25/08/2017
IV.2.7)

Conditions for opening of tenders

Date:  12/05/2017
Local time:  12:00
Place:  
Electronic postbox

Section VI: Complementary information

VI.1)

Information about recurrence

This is a recurrent procurement:  yes
VI.2)

Information about electronic workflows

Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
VI.4)

Procedures for review

VI.4.1)

Review body

Remedies Directive applies
Dublin
IE

VI.4.2)

Body responsible for mediation procedures

Remedies Directive applies
Dublin
IE

VI.5)

Date of dispatch of this notice

10/04/2017